Product Licensing and Regulations

Executive Summary

This page describes the steps taken to gain approval to launch a product in the European Union. We describe the work of the EMA in providing marketing authorisation (MA) for medicines, including the role of the CHMP, COMP and CAT. The Centralised, Decentralised and Mutual Recognition Procedures are explained, as are Conditional Approval and Approval Under Exceptional Circumstances.